Teglicar is a selective and reversible orally active liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1) inhibitor with an IC50 value of 0.68 μM and a Ki value of 0.36 μM. Teglicar has a potential antihyperglycemic propert. Teglicar can be used for the research of diabetes and neurodegenerative disease including Huntington's disease (HD).
PEGylation of Protein, Peptide & Oligo > Lipid Molecules > Cationic Lipid | Drug Delivery, Surface Modification > Lipid Molecules > Cationic Lipid | Products > Lipids In Drug Delivery > Cationic Lipid | Products > Lipids In Drug Delivery > Cationic Lipid > Carnitine
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.